Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, et al. Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene 2023 Mar 15. doi: 10.1038/s41388-023-02629.
PMID: 36922680